Summit Therapeutics
SMMT
$3.86
Share price
8.73%
Change (1 day)
192.42%
Change (1 year)
Categories
Summit Therapeutics (SMMT) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.12 B
According to Summit Therapeutics 's latest financial reports the company's total liabilities are $0.12 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Summit Therapeutics - Total liabilities on balance sheet (from 2020 to 2020)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.12 B | -76.7% |
| 2022-12-31 | $0.53 B | 1686.35% |
| 2021-12-31 | $30.09 M | 30.57% |
| 2020-12-31 | $23.04 M | |
| 2019-01-31 | $31.13 M | -73.36% |
| 2018-01-31 | $0.11 B | 82.08% |
| 2017-01-31 | $64.18 M | 252.4% |
| 2016-01-31 | $18.21 M | 24.53% |
| 2015-01-31 | $14.62 M | 112.17% |
| 2014-01-31 | $6.89 M | 81.03% |
| 2013-01-31 | $3.8 M | 3.6% |
| 2012-01-31 | $3.67 M | 3.84% |
| 2011-01-31 | $3.53 M | -56.95% |
| 2010-01-31 | $8.22 M | -25.52% |
| 2009-01-31 | $11.03 M | -63.76% |
| 2008-01-31 | $30.45 M | 145.16% |
| 2007-01-31 | $12.42 M | 180.31% |
| 2006-01-31 | $4.43 M | 571.7% |
| 2005-01-31 | $0.65 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $2.40 B | 1,820.24% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.44 M | -99.65% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | $0.82 B | 557.07% | 🇺🇸 USA |